Decentralized Trials Expand Access—but Risk Inequity
Remote clinical research is proliferating fast. The field is still working out who gets left behind.
-
By
-
Kerri Miller
-
April 15, 2026
-
-
1
The RESOLVE trial showed underrepresentation of Hispanic participants, highlighting inequities in decentralized trials.
-
2
Decentralized trials may shift participation barriers rather than eliminate them, affecting trial inclusivity.
-
3
Remote trials rely on technology that may disadvantage populations with lower digital fluency or access.
-
4
Hybrid trial models can enhance diversity by combining in-person and remote participation options.
-
5
Trial design must prioritize representativeness to ensure findings are generalizable across diverse populations.